Skip to content
Disclosery

ORBIMED ADVISORS LLC: DYN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on DYN, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 3,235,684 DYN shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 3,235,684 shares
    Change vs previous 13F +317,800 shares

    1.36% of the 13F portfolio, value $71,864,542.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,917,884 shares
    Change vs previous 13F +715,700 shares

    1.15% of the 13F portfolio, value $52,901,237.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,202,184 shares
    Change vs previous 13F -112,000 shares

    0.88% of the 13F portfolio, value $43,074,719.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,314,184 shares
    Change vs previous 13F +1,282,784 shares

    0.7% of the 13F portfolio, value $29,274,428.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,031,400 shares
    Change vs previous 13F +16,789 shares

    0.25% of the 13F portfolio, value $9,818,928.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,014,611 shares
    Change vs previous 13F -212,469 shares

    0.25% of the 13F portfolio, value $10,612,831.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,227,080 shares
    Change vs previous 13F +518,680 shares

    0.6% of the 13F portfolio, value $28,910,005.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 708,400 shares
    Change vs previous 13F not available

    0.47% of the 13F portfolio, value $25,445,728.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).